tirzepatide mace Everyone's picking a side. ๐๐๐ Let the Phase III data settle it. vs SEMAGLUTIDE The most important head-to-head in metabolic medicine right now. Swipe through all 9 slides ๐ โโโโโโโโโโโโโโโโโโโโโ ๐ฌ quicksilver audio ้
้้ ปๅบฆ:6ใซๆใใจ๏ผ24ๆฌ๏ผ GLP-1-based therapies, including GLP-1,
GLP-1-based therapies, including GLP-1, GLP-1R agonists and DPP-4... | Download Scientific Diagram
STEP 10 Group, Efficacy and safety of once-weekly semaglutide 2.4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial
quicksilver audio
้
้้ ปๅบฆ:6ใซๆใใจ๏ผ24ๆฌ๏ผ
it accounts for roughly 30% of tirzepatide's weight loss advantage over semaglutide in the SURMOUNT-1 vs STEP 1 comparison (Jastreboff et al., NEJM 2022